<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Article Tag Suite 1.1//EN"
  "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink"
         xmlns:mml="http://www.w3.org/1998/Math/MathML"
         article-type="research-article"
         xml:lang="en">
  <front>
    <journal-meta>
      <journal-title-group>
        <journal-title>American Journal of PharmTech Research</journal-title>
        <abbrev-journal-title abbrev-type="publisher">AJPTR</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="epub">2249-3387</issn>
      <publisher>
        <publisher-name>undefined</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">AJPTR61004</article-id>
      <title-group>
        <article-title>A Systematic Review on Synthetic Methods of Symmetric Triazines</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Rao</surname>
            <given-names>D.Srinivasa</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kumar</surname>
            <given-names>G.V.Pavan</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>B.Pooja</surname>
            <given-names>B.Pooja</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>G.Harika</surname>
            <given-names>G.Harika</given-names>
          </name>
        </contrib>
      </contrib-group>
      <pub-date pub-type="epub" iso-8601-date="2016-02-01">
        <month>02</month>
        <day>01</day>
        <year>2016</year>
      </pub-date>
      <volume>6</volume>
      <issue>1</issue>
      <abstract>
        <p>Triazines are interesting class of heterocyclic compounds. Various synthetic analogs of symmetric triazines have been prepared and evaluated for many pharmacological activities in different models with desired findings. Some analogs have shown potent pharmacological activity and may be considered as lead molecule for the development of future drugs. This review is an attempt to organize the chemical aspects of 1,3,5 triazine analogs reported till date systematically</p>
      </abstract>
      <kwd-group kwd-group-type="author">
        <kwd>Substituted 1</kwd>
        <kwd>3</kwd>
        <kwd>5-triazines</kwd>
        <kwd>chemical aspects</kwd>
        <kwd>pharmacological activities.</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <!-- Full article body not available in metadata-only JATS export. See PDF/HTML galley. -->
  </body>
  <back/>
</article>
